Share

More Pharmaceutical Industry Articles

  • America's other drug war

    Winston Churchill famously described an appeaser as "one who feeds a crocodile, hoping it will eat him last." Today, in a very different context, his remark captures the plight of the American pharmaceutical industry. Roughly five years after lobbyists for drugmakers worked to help pass...

  • Cheaper drugs can also mean less choice without savings for patients

    The economics of American healthcare are dictated by the Golden Rule: "He who has the gold makes the rules."

  • White House asks for $30M for CDC's Ebola efforts

    WASHINGTON (AP) — The White House on Friday sent Congress a request for $30 million to pay for the Center for Disease Control and Prevention's efforts to help contain the Ebola outbreak in western Africa. The administration wants the money added to a spending bill to keep government agencies...

  • Pharmacist arrested in tainted steroid case

    BOSTON (AP) — A pharmacist who oversaw the sterile clean rooms at a Massachusetts compounding pharmacy responsible for a deadly meningitis outbreak was arrested Thursday as he was about to board a flight for Hong Kong, federal officials said. Glenn Adam Chin, a former supervisory pharmacist at...

  • FDA OKs Merck drug, 1st in new cancer drug class

    TRENTON, N.J. (AP) — Merck & Co. on Thursday won the first U.S. approval for a new kind of cancer drug with big advantages over chemotherapy and other older cancer treatments. The Food and Drug Administration said it has granted accelerated approval to Merck's Keytruda, for treating melanoma...

  • Highmark sues UPMC over billing for cancer drugs

    PITTSBURGH (AP) — Health insurer Highmark Inc. has sued the University of Pittsburgh Medical Center claiming the hospital network has overbilled it by $300 million for cancer drugs since 2010. Highmark's lawsuit, filed late Wednesday, contends UPMC has been charging for chemotherapy treatments...

  • FDA: Little evidence to support testosterone drugs

    WASHINGTON (AP) — The Food and Drug Administration says there is little evidence that testosterone-boosting drugs taken by millions of American men are beneficial, though the agency is also unconvinced by studies suggesting the hormone carries serious risks. The agency posted its review online...



From the Weekly Standard

  • House of Cards

    Boston

    Read More...
  • Another Fight Obama Shirks

    When it comes to military actions, President Obama likes to declare the end of wars, regardless of whether America’s opponents agree that is the case. When it comes to economic wars, he has no...

    Read More...
  • Second Time’s a Charm?

    Voters in Connecticut’s gubernatorial election this November will face a familiar choice as Republican Tom Foley squares off against Democrat Dan Malloy. Four years ago, in a nail biter for what...

    Read More...